| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $256 | — |
| R&D Expense | $916K | +11.1% |
| SG&A Expense | $3.0M | +408.3% |
| Operating Income | -$4.0M | -182.0% |
| Net Income | -$3.9M | -177.8% |
| EPS (Basic) | -$4.00 | -2757.1% |
| EPS (Diluted) | -$4.00 | -2757.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.0M | +50.7% |
| Short-term Investments | $2.6M | — |
| Accounts Receivable | $8 | — |
| Current Assets | $3.6M | +312.6% |
| Total Assets | $3.7M | +292.6% |
| Current Liabilities | $270K | +5.6% |
| Total Liabilities | $270K | +5.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | -136.5% |
| Investing Cash Flow | -$2.5M | -3931.5% |
| Financing Cash Flow | $5.9M | +7901.3% |
| Stockholders' Equity |
| $3.4M |
| +399.6% |